NEW YORK (360Dx) – Veterinary drug company Zomedica Pharmaceuticals said today that it has entered into a research collaboration with liquid biopsy firm Celsee Diagnostics. Under the agreement, the companies plan to test the feasibility of Celsee’s circulating tumor cell detection and analysis technology for diagnosing cancer in dogs.

Financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.